OVERVIEW
The market for immunofluorescence assays is expected to reach USD 2.54 billion by 2024, rising at CAGR by 5.45% during the forecast period. Growing prevalence of chronic diseases, growing spending on R&D and increasing expenditure on health care are key factors driving market growth.
TABLE OF CONTENT
1 Global Immunofluorescence Assay MarketÂ
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope
2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
3 Global Immunofluorescence Assay Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography
4 Global Immunofluorescence Assay Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis
5 Global Immunofluorescence Assay Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies
6 Global Immunofluorescence Assay Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes
7 Global Immunofluorescence Assay Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)
8 Global Immunofluorescence Assay Market – By Product (Market Size – & million/billion)
8.1 Reagents
8.2 Instruments
8.3 Antibodies
8.4 Kits
8.5 Consumables and Accessories
9 Global Immunofluorescence Assay Market – By Type
9.1 Indirect Immunofluorescence
9.2 Direct Immunofluorescence
10 Global Immunofluorescence Assay Market – By Disease
10.1 Introduction
10.2 Cancer
10.3 Infectious Diseases
10.4 Autoimmune Diseases
10.5 Cardiovascular Diseases
10.6 Other
11 Global Immunofluorescence Assay Market – By End-User
11.1 Pharmaceutical and Biotechnology Companies
11.2 Academic and Research Institutes
11.3 Hospitals and Diagnostic Centers
11.4 Contract Research Organizations
12 Global Immunofluorescence Assay Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa
13 Global Immunofluorescence Assay Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships
14 Global Immunofluorescence Assay Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Thermo Fisher Scientific Inc.
14.3 Danaher Corporation
14.4 Merck Millipore
14.5 Abcam PLC
14.6 Bio-Rad Laboratories, Inc.
14.7 Perkinelmer Inc.
14.8 Sino Biological Inc.
14.9 Inova Diagnostics (A Part of Werfern Company)
14.10 Cell Signaling Technology, Inc.
14.11 Medipan GmbH
14.12 Company 11 & more
15 Global Immunofluorescence Assay Market – Appendix
15.1 Sources
15.2 Abbreviations